Wednesday, October 8, 2025

Latest

Mind Cure Launches Product Sales Division

Mind Cure Health (CSE: MCUR) continued its constant roll of news this week, announcing this morning that it has launched its nootropic and adaptogen products. The products are now available for purchase on the firms ecommerce platform, with shipping of products to commence next week.

The product launch marks the start of the firms sales division, with the first products to hit the market slated to target the mental hygiene and wellness segment. The first formulations consist of three noontropic formulations in both capsule and powder forms, as well as what as the firm refers to as a “teen-centric” formulation in capsule form.

The formulations are based on all-natural ingredients, utilizing various functional mushrooms, such as lion’s mane, reishi, and turkey tail, to provide healthy formulations to consumers.

“MINDCURE’s nootropic and adaptogen products are safe, unique, and packed with all-natural ingredients specifically chosen to promote mental performance. We’re eager to continue developing our product offerings to help in new and exciting ways.”

Sacha Hebbert, Senior Product & Marketing Manager

Mind Cure Health last traded at $0.61 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

Mind Cure Health Appoints Rob Hill To Board Of Directors

Mind Cure Health (CSE: MCUR) this morning announced the appointment of Rob Hill to the...

Monday, February 22, 2021, 09:12:53 AM

Mind Cure Gives Up On Psychedelics, Fires C-Suite, And Reverts To Shell After Strategic Review

In a sign of what’s to come for most psychedelic-related names, Mind Cure Health (CSE:...

Wednesday, March 16, 2022, 11:58:00 AM

Mind Cure Announces New Product, Launch Dates For Nootropic Products

Mind Cure Health (CSE: MCUR) this morning announced that it intends to bring a new...

Tuesday, December 29, 2020, 07:14:06 AM

Mind Cure Enters LOI To Acquire Ephiphany360 Digital Therapeutics Platform

Mind Cure Health (CSE: MCUR) is getting into the digital therapeutics space. The company announced...

Wednesday, October 21, 2020, 08:47:34 AM

Mind Cure Announces $10.0 Million Bought Deal Financing

Mind Cure Health (CSE: MCUR) this afternoon revealed that it is conducting a bought deal...

Thursday, January 21, 2021, 04:01:29 PM